Related references
Note: Only part of the references are listed.Micro and nanotechnologies: The little formulations that could
Rebeca T. Stiepel et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)
Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma
Hairong Wang et al.
ACS NANO (2022)
Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma
Jiaqi Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Towards principled design of cancer nanomedicine to accelerate clinical translation
Mohammad Souri et al.
MATERIALS TODAY BIO (2022)
Nanomedicine for brain cancer
Sabina Quader et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
The chick embryo chorioallantoic membrane as an experimental model to study in vivo angiogenesis in glioblastoma multiforme
Domenico Ribatti
BRAIN RESEARCH BULLETIN (2022)
Effect of post-diagnosis exercise on depression symptoms, physical functioning and mortality in breast cancer survivors: A systematic review and meta-analysis of randomized control trials
Abdul Salam et al.
CANCER EPIDEMIOLOGY (2022)
Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers
Masoud Farshbaf et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Receptor-mediated cascade targeting strategies for the application to medical diagnoses and therapeutics of glioma
Man Liang et al.
JOURNAL OF NANOPARTICLE RESEARCH (2022)
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy
Xuemeng Li et al.
PHARMACOLOGICAL RESEARCH (2022)
Integrin-alpha v beta 3 as a Therapeutic Target in Glioblastoma: Back to the Future?
William Echavidre et al.
PHARMACEUTICS (2022)
The Vascular Microenvironment in Glioblastoma: A Comprehensive Review
Alejandra Mosteiro et al.
BIOMEDICINES (2022)
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
Magdalena Jurczyk et al.
BIOMEDICINES (2022)
Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology
Catia Domingues et al.
ACS NANO (2022)
Regulatory Science Approach in Pharmaceutical Development of Follow-on Versions of Non-Biological Complex Drug Products
Daniela M. Zagalo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates
Toshihiko Tashima
BIOMEDICINES (2022)
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Nikhil Pandey et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma
Chunyan Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends
Arthur H. A. Sales et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs
Rodrigo dos A. Miguel et al.
PHARMACEUTICS (2022)
More than Toxins-Current Prospects in Designing the Next Generation of Antibody Drug Conjugates
Jonathan Schwach et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2022)
Antibody drug conjugate: the biological missile for targeted cancer therapy
Zhiwen Fu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Letter: Glioblastoma Cell of Origin
Ahmed Habib et al.
STEM CELL REVIEWS AND REPORTS (2022)
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Wenxing Gu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Polymeric nanoparticle vaccines to combat emerging and pandemic threats
David Wibowo et al.
BIOMATERIALS (2021)
WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer
Marta Puyol et al.
CLINICAL CANCER RESEARCH (2021)
Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis
Zheng Jin et al.
JOURNAL OF DRUG TARGETING (2021)
A quantitative view on multivalent nanomedicine targeting
Laura Woythe et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Targeted delivery of small noncoding RNA for glioblastoma
Ji Young Yoo et al.
CANCER LETTERS (2021)
pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment
Anbazhagan Sathiyaseelan et al.
CARBOHYDRATE POLYMERS (2021)
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
Juliana T. W. Tong et al.
MOLECULES (2021)
Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer
Muhammad Muzamil Khan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Central nervous system delivery of molecules across the blood-brain barrier
Fabien Gosselet et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges
Weisen Zhang et al.
ADVANCED SCIENCE (2021)
Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations
Catherine E. Vasey et al.
PHARMACEUTICS (2021)
Folate Receptors' Expression in Gliomas May Possess Potential Nanoparticle-Based Drug Delivery Opportunities
Eva McCord et al.
ACS OMEGA (2021)
Challenge to overcome current limitations of cell-penetrating peptides
Gyu Chan Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2021)
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
Jacob P. Fisher et al.
BIOMEDICINES (2021)
Area postrema syndrome in a patient with brainstem glioblastoma
K. S. Natsis et al.
ACTA NEUROLOGICA BELGICA (2021)
Effect of polymer source on in vitro drug release from PLGA microspheres
Bo Wan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Obstacles and opportunities in a forward vision for cancer nanomedicine
Irene de Lazaro et al.
NATURE MATERIALS (2021)
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging
Hamed Akbari et al.
SCIENTIFIC REPORTS (2021)
Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
Rikke Sick Andersen et al.
CANCERS (2021)
Advanced Immunotherapy Approaches for Glioblastoma
Yifan Ma et al.
ADVANCED THERAPEUTICS (2021)
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential
Lin Di et al.
DRUG DELIVERY (2021)
Emerging drug profile: CPX-351 (vyxeos) in AML
Mansour Alfayez et al.
LEUKEMIA & LYMPHOMA (2020)
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges
M. D. Al-Amin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies
Vanna Sanna et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
Bhavesh K. Ahir et al.
MOLECULAR NEUROBIOLOGY (2020)
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Frederik Soetaert et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas
Xiaowei Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs
Saba Naqvi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies
Akilandeswari A. Balachandran et al.
CANCERS (2020)
Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma
Yuexin Cui et al.
FRONTIERS IN ONCOLOGY (2020)
Caveolae-mediated transport at the injured blood-brain barrier as an underexplored pathway for central nervous system drug delivery
Alexander G. Sorets et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2020)
On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias
Xiaohe Tian et al.
SCIENCE ADVANCES (2020)
Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma
Alexander P. Landry et al.
SCIENTIFIC REPORTS (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation
Xiaoting Ren et al.
ACTA PHARMACEUTICA SINICA B (2019)
Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology
Rui Pedro Moura et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T
Y. -L. Wang et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2019)
The L-Type Amino Acid Transporter LAT1An Emerging Target in Cancer
Pascal Hafliger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures
Hongliang He et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma
Sushant Lakkadwala et al.
JOURNAL OF CONTROLLED RELEASE (2019)
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2-3, randomised, controlled trial
Sylvie Bonvalot et al.
LANCET ONCOLOGY (2019)
Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma
Xi Wang et al.
MOLECULES (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma
Shiyao Fu et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Brain metastases
Achal Singh Achrol et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Jann N. Sarkaria et al.
NEURO-ONCOLOGY (2018)
Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications
Claudia Martins et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
Y-K Kang et al.
ANNALS OF ONCOLOGY (2018)
Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides
Yaqin Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Dual-targeted nanomedicines for enhanced tumor treatment
Yaqin Zhu et al.
NANO TODAY (2018)
Multidimensional communication in the microenvirons of glioblastoma
Marike L. Broekman et al.
NATURE REVIEWS NEUROLOGY (2018)
Glioblastoma niches: from the concept to the phenotypical reality
Davide Schiffer et al.
NEUROLOGICAL SCIENCES (2018)
Facile construction of dual-targeting delivery system by using lipid capped polymer nanoparticles for anti-glioma therapy
Shengfeng Wang et al.
RSC ADVANCES (2018)
Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters
Cherry Kim et al.
CANCER MEDICINE (2018)
Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model
Sushant Lakkadwala et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma
Xufeng Zhu et al.
ACTA BIOMATERIALIA (2018)
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster et al.
BRITISH JOURNAL OF CANCER (2018)
Brain tumour post-treatment imaging and treatment-related complications
Alexander T. Kessler et al.
INSIGHTS INTO IMAGING (2018)
The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour
Stuart J. Smith et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Paclitaxel: What has been done and the challenges remain ahead
Ezequiel Bernabeu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Drug-induced amino acid deprivation as strategy for cancer therapy
Marcus Kwong Lam Fung et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Efficacy of NGR peptide-modified PEGylated quantum dots for crossing the blood-brain barrier and targeted fluorescence imaging of glioma and tumor vasculature
Ning Huang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
Jennifer P. Newman et al.
NATURE COMMUNICATIONS (2017)
Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment
Zakia Belhadj et al.
ONCOTARGET (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
The battle of nano paclitaxel
Alexandros Marios Sofias et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Evaluation of the use of therapeutic peptides for cancer treatment
Susan Marqus et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients
M. Mehta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB
Cuitian Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer
Julia Carnevale et al.
FUTURE ONCOLOGY (2016)
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
Peter P. Wibroe et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles
Lingyan Lv et al.
MOLECULAR PHARMACEUTICS (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine
Sang-Soo Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment
Brittany Voth et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling
Feng Liu et al.
MOLECULAR CELL (2015)
Design considerations for nanotherapeutics in oncology
Triantafyllos Stylianopoulos et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
Two decades of new drug development for central nervous system disorders
Aaron S. Kesselheim et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer
Iason T. Papademetriou et al.
THERAPEUTIC DELIVERY (2015)
Glioblastoma: Defining Tumor Niches
Dolores Hambardzumyan et al.
TRENDS IN CANCER (2015)
Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays
Huile Gao et al.
ACTA BIOMATERIALIA (2014)
Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment
Huile Gao et al.
BIOMATERIALS (2014)
RGD and Interleukin-13 Peptide Functionalized Nanoparticles for Enhanced Glioblastoma Cells and Neovasculature Dual Targeting Delivery and Elevated Tumor Penetration
Huile Gao et al.
MOLECULAR PHARMACEUTICS (2014)
Angiopep-2 and Activatable Cell-Penetrating Peptide Dual-Functionalized Nanoparticles for Systemic Glioma-Targeting Delivery
Huile Gao et al.
MOLECULAR PHARMACEUTICS (2014)
Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals
Taili Zong et al.
MOLECULAR PHARMACEUTICS (2014)
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
Pieter J. Gaillard et al.
PLOS ONE (2014)
Gliomas and the vascular fragility of the blood brain barrier
Luiz Gustavo Dubois et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells
Stacey Watkins et al.
NATURE COMMUNICATIONS (2014)
The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history
Norman R. Saunders et al.
FRONTIERS IN NEUROSCIENCE (2014)
Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes
Jian-Qing Gao et al.
BIOMATERIALS (2013)
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
Anna Golebiewska et al.
BRAIN (2013)
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
Jeffrey A. Silverman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma
Kevin Petrecca et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
Neil Senzer et al.
MOLECULAR THERAPY (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
Devin T. Wiley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Questioning the use of PEGylation for drug delivery
Johan J. F. Verhoef et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
Modern methods for delivery of drugs across the blood-brain barrier
Yan Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Huile Gao et al.
BIOMATERIALS (2012)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
Christoph Mamot et al.
LANCET ONCOLOGY (2012)
Transferrin-Modified c[RGDfK]-Paclitaxel Loaded Hybrid Micelle for Sequential Blood-Brain Barrier Penetration and Glioma Targeting Therapy
Pengcheng Zhang et al.
MOLECULAR PHARMACEUTICS (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas
Zhen Haining et al.
BMC CLINICAL PATHOLOGY (2012)
Prodrugs for improving tumor targetability and efficiency
Rubi Mahato et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Nanomedicine, nanotechnology in medicine
Patrick Boisseau et al.
COMPTES RENDUS PHYSIQUE (2011)
Mifamurtide for the treatment of nonmetastatic osteosarcoma
Kosei Ando et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
Klaus Maier-Hauff et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
The perivascular niche microenvironment in brain tumor progression
Nikki Charles et al.
CELL CYCLE (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
R. C. F. Leonard et al.
BREAST (2009)
MBP-426, a novel liposome-encapsulated oxaliplatin, in combination with 5-FU/leucovorin (LV): Phase I results of a Phase I/Il study in gastro-esophageal adenocarcinoma, with pharmacokinetics
Neil N. Senzer et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects
Joseph Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis
Hae Kyung Lee et al.
NEURO-ONCOLOGY (2008)
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
D. -W. Kim et al.
ANNALS OF ONCOLOGY (2007)
Expression of interleukin-13 receptor α2 in glioblastoma multiforme:: Implications for targeted therapies
John S. Jarboe et al.
CANCER RESEARCH (2007)
Molecular changes in the vasculature of injured tissues
Tero A. H. Jarvinen et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
FDA drug approval summary: Pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
Patricia Anne Dinndorf et al.
ONCOLOGIST (2007)
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
Hiroshi Nawashiro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Stress induction of GRP78/BiP and its role in cancer
JZ Li et al.
CURRENT MOLECULAR MEDICINE (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Food and Drug Administration drug approval summary: Temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme
MH Cohen et al.
CLINICAL CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
HER2 expression in breast cancer primary tumours and corresponding metastases.: Original data and literature review
J Carlsson et al.
BRITISH JOURNAL OF CANCER (2004)
Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients
S Ostermann et al.
CLINICAL CANCER RESEARCH (2004)
Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
S Hosokawa et al.
BRITISH JOURNAL OF CANCER (2003)